Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

8.43
Delayed Data
As of Jun 29
 +0.26 / +3.18%
Today’s Change
6.96
Today|||52-Week Range
25.25
-51.36%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Torley Helen I
President & Chief Executive Officer
Sale12/31/201516,436$17.33$284.8K-51.36%
Torley Helen I
President & Chief Executive Officer
Sale1/06/201611,686$15.77$184.3K-46.54%
Stelzer Laurie D
Chief Financial Officer
Buy8/20/201510,000$17.24$172.4K-50.93%
Kelley Kenneth J
Director
Buy8/28/201510,000$10.37$103.7K-54.21%
Falberg Kathryn E
Director
Buy1/13/201610,000$10.37$103.7K-16.20%
Countouriotis Athena
Chief Medical Officer & Senior Vice President
Sale12/31/20155,655$17.33$98.0K-51.36%
Torley Helen I
President & Chief Executive Officer
Sale2/06/201611,743$7.90$92.8K+15.16%
Countouriotis Athena
Chief Medical Officer & Senior Vice President
Sale1/05/20163,257$16.39$53.4K-48.57%
Matsui Connie L
Director
Buy9/14/201510,000$4.94$49.4K-52.85%
Falberg Kathryn E
Director
Buy1/13/201610,000$4.94$49.4K-16.20%
Page of 3